Live Breaking News & Updates on ஆண்டனி வெற்று

Stay updated with breaking news from ஆண்டனி வெற்று. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

CureVac Swiss AG Initiates Rolling Submission Process for mRNA-based COVID-19 Vaccine Candidate, CVnCoV, with Swissmedic


Press release content from Accesswire. The AP news staff was not involved in its creation.
CureVac Swiss AG Initiates Rolling Submission Process for mRNA-based COVID-19 Vaccine Candidate, CVnCoV, with Swissmedic
April 19, 2021 GMT
Review process started with submission of first CVnCoV data package
TÜBINGEN, GERMANY and BOSTON, MA / ACCESSWIRE / April 19, 2021 / The CureVac Swiss AG, the Swiss subsidiary of CureVac N.V. (Nasdaq:CVAC), a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA), today announced initiation of a rolling submission for CVnCoV, the company’s mRNA based COVID-19 vaccine candidate, for the use in Switzerland. The application for authorization was submitted to Swissmedic, the country’s authority responsible for the authorization and supervision of therapeutic products including vaccines. ....

United States , Antony Blanc , Sarah Fakih , Exchange Commission , European Union , European Medicines Agency , European Commission , Curevac Swiss , Chief Business Officer , Chief Commercial Officer , Latin America , Lipid Nanoparticles , New York Nasdaq , Vice President , Vice President Investor , Public Health , Government Business And Finance , Products And Services , Government Regulations , Coronavirus Pandemic , Product Testing , Government Contracts , Pharmaceutical Manufacturing , Health Care Industry , Lung Disease , Covid 19 Pandemic ,